ASX Announcement

FDA Approves Cambium Bio's Potency Assay Strategy for Elate

Published: 18/03/25, 10:58am (AEST)2 pages
Cambium Bio
CMB:ASXHealthcare

Recent CMB Announcements

Price Sensitive only